I suppose there's only so much can be divulged as being fact when the collaboration has just begun, but we can speculate.
I had a run through
@Phantom1 's content tonight and here's a few observations.
Firstly, I really appreciate the upfront and ongoing disclosure that he/she has an association with some of the RAP research; what capacity I don't know, but good to know.
Secondly, and I'm sorry to imply a link here if there isn't one, but contributions tend to be at times when we're looking for clarity. Like today.
Looking back, Phantom posted about the ERS International Conference in Spain (Sept/Oct '19) on September 5. Our participation in Creaosphere ws announced October 4. On October 23, Phantom posted about a paper out of WA and our tech's capacity to replicate (?) the Pulmonary Score results in asthma. This was also day one of Creaosphere.
Today an mou of sorts with Sanofi, with their integrated health platform (ongoing monitoring).
Joining the dots to me implies perhaps an integrated virtual asthma monitoring and treatment solution.
It's only an opinion and I'm happy to be corrected if I'm wrong.
Would be cool though...
